drugset / Trial / NCT06182267
Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101
RandomizedCrossoverQuadruple-blindTreatment
Summary
Pharmacokinetic (PK) study of L-arginine after exaggerated oral use of the novel dentifrice product COL101 after repeated daily applications in healthy adult subjects.
Timeline
- Start
- 2023-11-27
- Primary completion
- 2023-12-22
- Completion
- 2023-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-arginine | Small molecule | 8 % | Oral |
| Background | sodium fluoride | Unknown | 0.24 % | Oral |